Dai Xiaosong - Net Worth and Insider Trading
Dai Xiaosong Net Worth
The estimated net worth of Dai Xiaosong is at least $21 Million dollars as of 2024-11-08. Dai Xiaosong is the of New Ray Medicine International Holding Ltd and owns about 426,672,000 shares of New Ray Medicine International Holding Ltd (HKSE:06108) stock worth over $21 Million. Details can be seen in Dai Xiaosong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dai Xiaosong has not made any transactions after 2023-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dai Xiaosong
Dai Xiaosong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dai Xiaosong owns 1 companies in total, including New Ray Medicine International Holding Ltd (HKSE:06108) .
Click here to see the complete history of Dai Xiaosong’s form 4 insider trades.
Insider Ownership Summary of Dai Xiaosong
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06108 | New Ray Medicine International Holding Ltd | 2023-07-25 |
Dai Xiaosong Latest Holdings Summary
Dai Xiaosong currently owns a total of 1 stock. Dai Xiaosong owns 426,672,000 shares of New Ray Medicine International Holding Ltd (HKSE:06108) as of July 25, 2023, with a value of $21 Million.
Latest Holdings of Dai Xiaosong
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06108 | New Ray Medicine International Holding Ltd | 2023-07-25 | 426,672,000 | 0.05 | 20,906,928 |
Holding Weightings of Dai Xiaosong
Dai Xiaosong Form 4 Trading Tracker
According to the SEC Form 4 filings, Dai Xiaosong has made a total of 2 transactions in New Ray Medicine International Holding Ltd (HKSE:06108) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in New Ray Medicine International Holding Ltd is the sale of 0 shares on July 25, 2023, which brought Dai Xiaosong around $0.
Insider Trading History of Dai Xiaosong
- 1
Dai Xiaosong Trading Performance
Dai Xiaosong Ownership Network
Ownership Network List of Dai Xiaosong
Ownership Network Relation of Dai Xiaosong
Dai Xiaosong Owned Company Details
What does New Ray Medicine International Holding Ltd do?
Who are the key executives at New Ray Medicine International Holding Ltd?
Dai Xiaosong is the of New Ray Medicine International Holding Ltd. Other key executives at New Ray Medicine International Holding Ltd include Eagle Amber Holdings Limited , 2201 Interest of corporation controlled by you Chu Xueping , and 2101 Beneficial owner Qian Shenglei .
New Ray Medicine International Holding Ltd (HKSE:06108) Insider Trades Summary
Over the past 18 months, Dai Xiaosong made 1 insider transaction in New Ray Medicine International Holding Ltd (HKSE:06108) with a net sale of 0. Other recent insider transactions involving New Ray Medicine International Holding Ltd (HKSE:06108) include a net sale of 0 shares made by Chu Xueping , a net sale of 0 shares made by Eagle Amber Holdings Limited ,
In summary, during the past 3 months, insiders sold 0 shares of New Ray Medicine International Holding Ltd (HKSE:06108) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of New Ray Medicine International Holding Ltd (HKSE:06108) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
New Ray Medicine International Holding Ltd (HKSE:06108)'s detailed insider trading history can be found in Insider Trading Tracker table.
New Ray Medicine International Holding Ltd Insider Transactions
Dai Xiaosong Mailing Address
Above is the net worth, insider trading, and ownership report for Dai Xiaosong. Currently GuruFocus does not have mailing address information for Dai Xiaosong.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
